New developments in infective endocarditis.
Rev Esp Cardiol (Engl Ed)
; 77(9): 779-787, 2024 Sep.
Article
em En, Es
| MEDLINE
| ID: mdl-38763212
ABSTRACT
Infective endocarditis is a continually evolving disease. Present-day patients differ significantly from those treated a few decades ago they tend to be older and have more comorbidities and health care-related episodes, while new groups of patients have emerged with new types of endocarditis, such as those affecting patients with percutaneous valve prostheses. There have also been changes in diagnostic techniques. Although transthoracic and transesophageal echocardiography are still the most commonly used imaging modalities, other techniques, such as 3-dimensional transesophageal ultrasound, cardiac computed tomography, and nuclear medicine tests (PET/CT and SPECT/CT), are increasingly used for diagnosing both the disease and its complications. In recent years, there have also been significant developments in antibiotic therapy. Currently, several treatment strategies are available to shorten the hospital phase of the disease in selected patients, which can reduce the complications associated with hospitalization, improve the quality of life of patients and their families, and reduce the health care costs of the disease. This review discusses the main recent epidemiological, diagnostic and therapeutic developments in infective endocarditis.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Endocardite
Limite:
Humans
Idioma:
En
/
Es
Revista:
Rev Esp Cardiol (Engl Ed)
Ano de publicação:
2024
Tipo de documento:
Article